Pular para o conteúdo principal
Ranking Invest

SYK - Stryker Corporation

Segmento: HealthcareStryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Análise Ranking Invest

Valuation estimado
$ 34.61 Bi
Valor de Mercado
$ 105.70 Bi
Sobrepreço (AV)+205.4%
IVR
0.33A companhia vale 0,33 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.11O valuation alternativo equivale a 11% do valor de mercado da companhia.
MLL
0.11O lucro líquido dos controladores em 16 trimestres equivale a 11% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 23.99 Bi

Dívida Líquida

$ 11.55 Bi

L4T

$ 3.73 Bi

MM4T

14.44%

Indicadores Básicos

ROE

15.55%

Índices de Previsibilidade

Receita Líquida

C0.05

Lucro

B0.15

Margem

B0.16

Índices de Tendência

Receita Líquida

B10.33

Lucro

B4.93

Margem

D-0.88

Índices de Endividamento

DIV/PAT

0.48

DIV/L4T

3.10

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.